BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Treatment
29 results:

  • 1. Assessment of artificial intelligence (AI) reporting methodology in glioma MRI studies using the Checklist for AI in Medical Imaging (CLAIM).
    Bhandari A; Scott L; Weilbach M; Marwah R; Lasocki A
    Neuroradiology; 2023 May; 65(5):907-913. PubMed ID: 36746792
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Establishment and Characterization of Carboplatin-Resistant Retinoblastoma cell Lines.
    Cho CS; Jo DH; Kim JH; Kim JH
    Mol Cells; 2022 Oct; 45(10):729-737. PubMed ID: 36047446
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological characteristics and prognosis of gastrointestinal vascular tumours.
    Haibin Z; Lingling W; Lexing Z; Xumin B; Yingyu W; Jianfeng Y; Xiaofeng Z
    Sci Rep; 2021 Aug; 11(1):16062. PubMed ID: 34373472
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer treatment.
    Cheng B; Wang W; Niu X; Ren Y; Liu T; Cao H; Wang S; Tu Y; Chen J; Liu S; Yang X; Chen J
    J Med Chem; 2020 Dec; 63(24):15946-15959. PubMed ID: 33264007
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Glioblastoma post-operative imaging in neuro-oncology: current UK practice (GIN CUP study).
    Booth TC; Luis A; Brazil L; Thompson G; Daniel RA; Shuaib H; Ashkan K; Pandey A
    Eur Radiol; 2021 May; 31(5):2933-2943. PubMed ID: 33151394
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (cdkn2c) loss assay in sporadic medullary thyroid carcinoma.
    Maxwell JE; Gule-Monroe MK; Subbiah V; Hu M; Perrier ND; Cabanillas ME; Lee JE; Graham PH; Cote GJ; Busaidy NL; Grubbs EG
    Surgery; 2020 Jan; 167(1):80-86. PubMed ID: 31648931
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic factors associated with survival in patients with anaplastic oligodendroglioma.
    Liu S; Liu X; Xiao Y; Chen S; Zhuang W
    PLoS One; 2019; 14(1):e0211513. PubMed ID: 30699183
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR‑34a derived from mesenchymal stem cells stimulates senescence in glioma cells by inducing DNA damage.
    Li Q; Wang C; Cai L; Lu J; Zhu Z; Wang C; Su Z; Lu X
    Mol Med Rep; 2019 Mar; 19(3):1849-1857. PubMed ID: 30592284
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Management of placental site trophoblastic tumor: Two case reports.
    De Nola R; Schönauer LM; Fiore MG; Loverro M; Carriero C; Di Naro E
    Medicine (Baltimore); 2018 Nov; 97(48):e13439. PubMed ID: 30508960
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. AG1031 induces apoptosis through suppressing SIRT1/p53 pathway in human neuroblastoma cells.
    Fu J; Zhang H; Zhang Y; Zhang T
    Mol Cell Biochem; 2019 Apr; 454(1-2):165-175. PubMed ID: 30350304
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional treatment Options.
    Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
    Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.
    Cohen PR; Tomson BN; Elkin SK; Marchlik E; Carter JL; Kurzrock R
    Oncotarget; 2016 Apr; 7(17):23454-67. PubMed ID: 26981779
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pathologic complete response to intralesional interleukin-2 therapy associated with improved survival in melanoma patients with in-transit disease.
    Hassan S; Petrella TM; Zhang T; Kamel-Reid S; Nordio F; Baccarelli A; Sade S; Naert K; Habeeb AA; Ghazarian D; Wright FC
    Ann Surg Oncol; 2015; 22(6):1950-8. PubMed ID: 25366584
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. High-throughput sequencing of the melanoma genome.
    Kunz M; Dannemann M; Kelso J
    Exp Dermatol; 2013 Jan; 22(1):10-7. PubMed ID: 23174022
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the german Speaking Society of Pediatric Oncology and Hematology.
    Gnekow AK; Falkenstein F; von Hornstein S; Zwiener I; Berkefeld S; Bison B; Warmuth-Metz M; Driever PH; Soerensen N; Kortmann RD; Pietsch T; Faldum A
    Neuro Oncol; 2012 Oct; 14(10):1265-84. PubMed ID: 22942186
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.
    Cen L; Carlson BL; Schroeder MA; Ostrem JL; Kitange GJ; Mladek AC; Fink SR; Decker PA; Wu W; Kim JS; Waldman T; Jenkins RB; Sarkaria JN
    Neuro Oncol; 2012 Jul; 14(7):870-81. PubMed ID: 22711607
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The risk factors of symptomatic communicating hydrocephalus after stereotactic radiosurgery for unilateral vestibular schwannoma: the implication of brain atrophy.
    Han JH; Kim DG; Chung HT; Paek SH; Park CK; Kim CY; Hwang SS; Park JH; Kim YH; Kim JW; Kim YH; Song SW; Kim IK; Jung HW
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):937-42. PubMed ID: 22494587
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
    Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
    Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine.
    Dangoor A; Lorigan P; Keilholz U; Schadendorf D; Harris A; Ottensmeier C; Smyth J; Hoffmann K; Anderson R; Cripps M; Schneider J; Hawkins R
    Cancer Immunol Immunother; 2010 Jun; 59(6):863-73. PubMed ID: 20043222
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.
    Ayrault O; Godeny MD; Dillon C; Zindy F; Fitzgerald P; Roussel MF; Beere HM
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17037-42. PubMed ID: 19805107
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.